Harbour Investments, Inc. Brainstorm Cell Therapeutics Inc. Transaction History

Harbour Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.2 - $2.08 $135 - $1,412	-679 Reduced 46.03%	796 $0
Q1 2023 May 15, 2023	SELL	$1.43 - $3.3 $437 - $1,009	-306 Reduced 17.18%	1,475 $4,000
Q4 2022 Feb 15, 2023	SELL	$1.37 - $4.42 $1,168 - $3,770	-853 Reduced 32.38%	1,781 $2,000
Q2 2022 Aug 15, 2022	SELL	$2.71 - $3.6 $4,783 - $6,354	-1,765 Reduced 40.12%	2,634 $7,000
Q4 2021 Feb 16, 2022	SELL	$2.81 - $4.23 $10,874 - $16,370	-3,870 Reduced 46.8%	4,399 $18,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $3,689 - $4,805	-1,175 Reduced 12.44%	8,269 $27,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $33 - $44	-11 Reduced 0.12%	9,444 $36,000
Q1 2021 Aug 17, 2021	BUY	$3.46 - $7.88 $32,714 - $74,505	9,455 New	9,455 $36,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.